Sunshine Biopharma, Inc. Looking to Mimic Roche’s Billion Dollar Cancer Drug Success

MONTREAL, July 27, 2011 (GLOBE NEWSWIRE) -- Last year, over 260,000 new cases of breast cancer (invasive and in situ combined) were diagnosed in women in the United States. Over the course of a woman's lifetime, the odds are greater than 12 percent – or 1 out of every 8 – that she will develop invasive breast cancer and have only about a 41 percent chance of surviving for five years if not detected until stage IIIB (odds are increased to approximately 90 percent if caught in stage I). Although most people don't consider it, men aren't removed from invasive breast cancer stats either; nearly 2,000 new cases were diagnosed in 2010 as well.